Teva entreats SCOTUS to block Copaxone generics till patent case wraps

Save

Teva Pharmaceutical Industries has finally convinced the Supreme Court to hear its Copaxone patent appeal. But the high court may not hand down a decision till June 2015–and generic versions of the company's top moneymaker are on their way as soon as next month.